Market cap
₹146 Cr
Revenue (TTM)
₹37 Cr
P/E Ratio
31.1
P/B Ratio
3.1
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -10.82 | 216.08 | 125.54 | -10.80 | -6.87 |
| EBIT | -1.36 | 1,095.83 | 950.55 | 35.30 | 0.42 |
| Net Profit | -2.06 | 1,095.24 | 582.58 | 15.93 | -7.01 |
| EPS | 7.64 | 1,095.13 | 568.91 | 15.14 | -7.38 |
| Book Value | -- | -- | 7.87 | 10.66 | 10.15 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Mar-26 | Mar-25 |
| EBIT-Margin
| 17.30 | 13.05 | 26.07 | 23.41 | 10.63 |
| Net Margin
| 11.36 | 8.82 | 12.08 | 10.79 | 9.17 |
| Return on equity
| 10.90 | 9.92 | 10.63 | 7.91 | 4.33 |
| Return on Capital
| 11.11 | 11.09 | -- | 9.17 | 3.79 |
| Return on Assets
| 5.40 | 5.29 | 4.25 | 3.21 | 1.99 |
| Debt to Equity (x)
| -- | -- | 0.00 | 1.37 | 1.05 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Auro Laboratories
|
--
|
9.17
|
3.79
|
20.37
|
9.92
|
|
Peer Median
|
--
|
15.48
|
16.46
|
15.49
|
--
|
ROE
10.63
Higher than Peers by 0.68
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Auro Laboratories
|
10.63
|
7.91
|
4.33
|
20.46
|
7.43
|
|
Peer Median
|
9.94
|
12.68
|
13.87
|
14.72
|
--
|
ROA
4.25
Lower than Peers by 3.00
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Auro Laboratories
|
4.25
|
3.21
|
1.99
|
11.00
|
4.40
|
|
Peer Median
|
7.26
|
7.69
|
8.04
|
7.19
|
--
|
EBIT Margin
26.07
Higher than Peers by 16.53
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Auro Laboratories
|
26.07
|
23.41
|
10.63
|
17.86
|
6.27
|
|
Peer Median
|
9.55
|
15.68
|
10.05
|
10.28
|
--
|
Net Margin
12.08
Higher than Peers by 3.44
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Auro Laboratories
|
12.08
|
10.79
|
9.17
|
14.13
|
4.54
|
|
Peer Median
|
8.64
|
11.16
|
9.11
|
6.78
|
--
|
Cash Profit Margin
--
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Auro Laboratories
|
--
|
20.63
|
15.35
|
16.56
|
6.65
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
125.54
Higher than Peers by 119.30
Year on year growth in net sales
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Auro Laboratories
|
125.54
|
60.74
|
-64.34
|
1.40
|
3.99
|
|
Peer Median
|
6.24
|
15.05
|
7.17
|
10.56
|
--
|
EBIT Growth
950.55
Higher than Peers by 950.61
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Auro Laboratories
|
950.55
|
254.01
|
-78.78
|
188.60
|
-8.02
|
|
Peer Median
|
-0.06
|
19.88
|
12.05
|
6.17
|
--
|
Net Profit Growth
582.58
Higher than Peers by 575.00
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Auro Laboratories
|
582.58
|
92.14
|
-76.40
|
219.09
|
-14.15
|
|
Peer Median
|
7.58
|
19.11
|
22.15
|
27.97
|
--
|
EPS Growth
568.91
Higher than Peers by 566.73
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Auro Laboratories
|
568.91
|
92.14
|
-76.40
|
219.09
|
-14.15
|
|
Peer Median
|
2.18
|
23.11
|
8.80
|
--
|
--
|
Book Value Growth
--
--
Year on year growth in book value per share
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Auro Laboratories
|
--
|
7.87
|
2.41
|
22.68
|
8.50
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Auro Laboratories
|
--
|
1.37
|
1.05
|
0.63
|
0.19
|
|
Peer Median
|
0.02
|
0.12
|
0.03
|
0.05
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Auro Laboratories
|
--
|
0.39
|
0.24
|
0.19
|
0.12
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.08
Lower than Peers by 1.37
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Auro Laboratories
|
1.08
|
1.08
|
0.96
|
1.29
|
1.97
|
|
Peer Median
|
2.45
|
2.48
|
2.20
|
1.93
|
--
|
Quick Ratio
0.60
Lower than Peers by 1.11
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Auro Laboratories
|
0.60
|
0.60
|
0.79
|
0.94
|
1.32
|
|
Peer Median
|
1.72
|
1.82
|
1.72
|
1.59
|
--
|
Interest Coverage
2.13
Lower than Peers by 7.58
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Auro Laboratories
|
2.13
|
2.13
|
2.74
|
15.06
|
5.23
|
|
Peer Median
|
9.71
|
13.67
|
12.28
|
12.45
|
--
|
Operating Efficiency
Debtors to sales
24.85
Lower than Peers by 2.07
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Auro Laboratories
|
24.85
|
29.77
|
49.12
|
24.97
|
23.45
|
|
Peer Median
|
26.91
|
30.65
|
26.23
|
23.97
|
--
|
Asset Turnover
0.33
Lower than Peers by 0.34
Sales / Average Total Assets
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Auro Laboratories
|
0.33
|
0.28
|
0.21
|
0.76
|
0.95
|
|
Peer Median
|
0.67
|
0.70
|
0.74
|
0.88
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Auro Laboratories
|
--
|
110.10
|
217.45
|
87.78
|
89.77
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Auro Laboratories
|
--
|
102.16
|
113.63
|
68.04
|
55.24
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Auro Laboratories
|
--
|
327.89
|
246.16
|
121.53
|
83.56
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Auro Laboratories
|
--
|
-115.63
|
84.92
|
34.28
|
61.45
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
31.08
Lower than Peers by 24.71
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Auro Laboratories
|
31.08
|
46.75
|
78.15
|
12.89
|
13.95
|
|
Peer Median
|
55.79
|
55.79
|
39.17
|
40.74
|
--
|
Price / Book Value
3.07
Lower than Peers by 1.41
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Auro Laboratories
|
3.07
|
3.56
|
3.34
|
2.39
|
1.00
|
|
Peer Median
|
4.48
|
4.80
|
3.61
|
3.87
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Auro Laboratories
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.14
|
0.14
|
0.19
|
0.20
|
--
|
EV/EBITDA
13.83
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Auro Laboratories
|
13.83
|
18.88
|
46.33
|
10.27
|
7.13
|
|
Peer Median
|
--
|
39.94
|
28.79
|
25.41
|
--
|
Market Cap
146
Lower than Peers by 5,316
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Auro Laboratories
|
146
|
165
|
144
|
100
|
34
|
|
Peer Median
|
5,461
|
5,461
|
3,944
|
2,959
|
--
|